Tian‐Li Wang

27.7k total citations · 1 hit paper
201 papers, 12.6k citations indexed

About

Tian‐Li Wang is a scholar working on Molecular Biology, Reproductive Medicine and Cancer Research. According to data from OpenAlex, Tian‐Li Wang has authored 201 papers receiving a total of 12.6k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Molecular Biology, 67 papers in Reproductive Medicine and 40 papers in Cancer Research. Recurrent topics in Tian‐Li Wang's work include Ovarian cancer diagnosis and treatment (65 papers), Chromatin Remodeling and Cancer (28 papers) and Cancer Mechanisms and Therapy (28 papers). Tian‐Li Wang is often cited by papers focused on Ovarian cancer diagnosis and treatment (65 papers), Chromatin Remodeling and Cancer (28 papers) and Cancer Mechanisms and Therapy (28 papers). Tian‐Li Wang collaborates with scholars based in United States, Taiwan and China. Tian‐Li Wang's co-authors include Ie‐Ming Shih, Robert J. Kurman, Ie−Ming Shih, Victor E. Velculescu, Kenneth W. Kinzler, Bert Vogelstein, Kentaro Nakayama, Ben Davidson, Tsui-Lien Mao and Bin Guan and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Tian‐Li Wang

195 papers receiving 12.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma

2010 923 citations Tian‐Li Wang, Ie‐Ming Shih et al. Science profile →

Peers

Countries citing papers authored by Tian‐Li Wang

Since Specialization

Citations

This map shows the geographic impact of Tian‐Li Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tian‐Li Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tian‐Li Wang more than expected).

Fields of papers citing papers by Tian‐Li Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tian‐Li Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tian‐Li Wang. The network helps show where Tian‐Li Wang may publish in the future.

Co-authorship network of co-authors of Tian‐Li Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Tian‐Li Wang. A scholar is included among the top collaborators of Tian‐Li Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tian‐Li Wang. Tian‐Li Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Systems medicine dissection of chr1q-amp reveals a novel PBX1-FOXM1 axis for targeted therapy in multiple myeloma 2022 ·Blood ·(unknown), (unknown), (unknown), Yao Shen, Ioannis V. Kostopoulos, (unknown), (unknown), (unknown), Xiaolin Xiao, Richard Szydlo, Pierangela Sabbattini, Irene Roberts, Holger W. Auner, Kikkeri N. Naresh, Aristeidis Chaidos, Tian‐Li Wang, Luca Magnani, Valentina S. Caputo, Anastasios Karadimitris	20
2	Methylomic Landscapes of Ovarian Cancer Precursor Lesions 2020 ·Clinical Cancer Research ·Thomas R. Pisanic, Yeh Wang, (unknown), Michael Considine, Lihong Li, Tza‐Huei Wang, Tian‐Li Wang, Ie‐Ming Shih	19
3	PVRIG and PVRL2 Are Induced in Cancer and Inhibit CD8+ T-cell Function 2019 ·Cancer Immunology Research ·Sarah Whelan, Eran Ophir, Maya F. Kotturi, Ofer Levy, Sudipto Ganguly, Ling Yan Leung, Ilan Vaknin, Sandeep Kumar, (unknown), Kyle Hansen, (unknown), (unknown), Abha Soni, Janis M. Taube, Amanda N. Fader, Tian‐Li Wang, Ie‐Ming Shih, Mark A. White, Drew M. Pardoll, Spencer C. Liang	125
4	Loss of ARID1A in Tumor Cells Renders Selective Vulnerability to Combined Ionizing Radiation and PARP Inhibitor Therapy 2019 ·Clinical Cancer Research ·Youngran Park, M. Herman Chui, Yohan Suryo Rahmanto, (unknown), Raghavendra A. Shamanna, Marina A. Bellani, Stéphanie Gaillard, A. Ayhan, Akila Viswanathan, Michael M. Seidman, Sonia Franco, Anthony K. L. Leung, Vilhelm A. Bohr, Ie‐Ming Shih, Tian‐Li Wang	95
5	Methylomic Analysis of Ovarian Cancers Identifies Tumor-Specific Alterations Readily Detectable in Early Precursor Lesions 2018 ·Clinical Cancer Research ·Thomas R. Pisanic, Leslie Cope, Shiou‐Fu Lin, Ting‐Tai Yen, Pornpat Athamanolap, Ryoichi Asaka, Kentaro Nakayama, Amanda N. Fader, Tza‐Huei Wang, Ie‐Ming Shih, Tian‐Li Wang	42
6	Fallopian Tube Lesions in Women at High Risk for Ovarian Cancer: A Multicenter Study 2018 ·Cancer Prevention Research ·Kala Visvanathan, Patricia Shaw, (unknown), Asli Bahadirli-Talbott, (unknown), Harvey A. Risch, Steven A. Narod, Tian‐Li Wang, Vinita Parkash, Russell Vang, Douglas A. Levine, Robert A. Soslow, Robert J. Kurman, Ie‐Ming Shih	49
7	Ovarian Cancer Chemoresistance Relies on the Stem Cell Reprogramming Factor PBX1 2016 ·Cancer Research ·(unknown), Ie−Ming Shih, Joon Tae Park, (unknown), (unknown), A. Ayhan, Karen Handschuh, Ben Davidson, Amanda N. Fader, Licia Selleri, Tian‐Li Wang	62
8	Mevalonate Pathway Antagonist Suppresses Formation of Serous Tubal Intraepithelial Carcinoma and Ovarian Carcinoma in Mouse Models 2015 ·Clinical Cancer Research ·Yusuke Kobayashi, Hiroyasu Kashima, Ren‐Chin Wu, (unknown), (unknown), Jinghua Gu, Jianhua Xuan, Lori J. Sokoll, Kala Visvanathan, Ie‐Ming Shih, Tian‐Li Wang	49
9	NAC1 Is an Actin-Binding Protein That Is Essential for Effective Cytokinesis in Cancer Cells 2012 ·Cancer Research ·Kai Lee Yap, Stephanie I. Fraley, Michelle M. Thiaville, Natini Jinawath, Kentaro Nakayama, Jianlong Wang, Tian‐Li Wang, Denis Wirtz, Ie‐Ming Shih	33
10	Defining NOTCH3 Target Genes in Ovarian Cancer 2012 ·Cancer Research ·Xu Chen, Michelle M. Thiaville, Li Chen, Alexander Stoeck, Jianhua Xuan, Min Gao, Ie‐Ming Shih, Tian‐Li Wang	56
11	ARID1A , a Factor That Promotes Formation of SWI/SNF-Mediated Chromatin Remodeling, Is a Tumor Suppressor in Gynecologic Cancers 2011 ·Cancer Research ·Bin Guan, Tian‐Li Wang, Ie‐Ming Shih	353
12	DNA Copy Numbers Profiles in Affinity-Purified Ovarian Clear Cell Carcinoma 2010 ·Clinical Cancer Research ·Kuan‐Ting Kuo, Tsui-Lien Mao, Xu Chen, Yuanjian Feng, Kentaro Nakayama, Yue Wang, Ruth Glas, Min-Ho Joe, Robert J. Kurman, Ie‐Ming Shih, Tian‐Li Wang	75
13	Analysis of DNA Copy Number Alterations in Ovarian Serous Tumors Identifies New Molecular Genetic Changes in Low-Grade and High-Grade Carcinomas 2009 ·Cancer Research ·Kuan‐Ting Kuo, Bin Guan, Yuanjian Feng, Tsui-Lien Mao, Xu Chen, Natini Jinawath, Yue Wang, Robert J. Kurman, Ie‐Ming Shih, Tian‐Li Wang	136
14	Functional Genomic Analysis Identified Epidermal Growth Factor Receptor Activation as the Most Common Genetic Event in Oral Squamous Cell Carcinoma 2009 ·Cancer Research ·Jim Jinn‐Chyuan Sheu, Chun-Hung Hua, Lei Wan, Ying‐Ju Lin, Ming-Tsung Lai, Hsien-Chang Tseng, Natini Jinawath, Ming-Hsui Tsai, Nai-Wen Chang, (unknown), (unknown), (unknown), Tian‐Li Wang, Ie‐Ming Shih, Fuu‐Jen Tsai	132
15	The Roles of Human Sucrose Nonfermenting Protein 2 Homologue in the Tumor-Promoting Functions of Rsf-1 2008 ·Cancer Research ·Jim Jinn‐Chyuan Sheu, Jung‐Hye Choi, (unknown), Fuu‐Jen Tsai, Yosef Shaul, Tian‐Li Wang, Ie−Ming Shih	48
16	Identification of Pbx1 , a Potential Oncogene, as a Notch3 Target Gene in Ovarian Cancer 2008 ·Cancer Research ·Joon T. Park, Ie‐Ming Shih, Tian‐Li Wang	64
17	Jagged-1 and Notch3 Juxtacrine Loop Regulates Ovarian Tumor Growth and Adhesion 2008 ·Cancer Research ·Jung‐Hye Choi, Joon T. Park, Ben Davidson, Patrice J. Morin, Ie‐Ming Shih, Tian‐Li Wang	102
18	NAC-1 Controls Cell Growth and Survival by Repressing Transcription of Gadd45GIP1, a Candidate Tumor Suppressor 2007 ·Cancer Research ·Kentaro Nakayama, Naomi Nakayama, Tian‐Li Wang, Ie‐Ming Shih	63
19	Gene Expression Signatures Differentiate Ovarian/Peritoneal Serous Carcinoma from Diffuse Malignant Peritoneal Mesothelioma 2006 ·Clinical Cancer Research ·Ben Davidson, Zhen Zhang, Lilach Kleinberg, Mei Li, Viví Ann Flørenes, Tian‐Li Wang, Ie‐Ming Shih	88
20	Mutational Analysis of the Tyrosine Phosphatome in Colorectal Cancers 2004 ·Science ·Zhenghe Wang, Dong Shen, D. Williams Parsons, Alberto Bardelli, Jason A. Sager, Steve Szabo, Janine Ptak, Natalie Silliman, Brock A. Peters, Michiel S. van der Heijden, Giovanni Parmigiani, Hai Yan, Tian‐Li Wang, Greg Riggins, Steven M. Powell, James K. V. Willson, Sanford D. Markowitz, Kenneth W. Kinzler, Bert Vogelstein, Victor E. Velculescu	412

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact